Viewing Study NCT00093457


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2025-12-31 @ 1:57 AM
Study NCT ID: NCT00093457
Status: COMPLETED
Last Update Posted: 2023-08-04
First Post: 2004-10-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer
Sponsor: NCIC Clinical Trials Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent prostate cancer View
None stage IV prostate cancer View
None adenocarcinoma of the prostate View